Research recommendations coming out of this guidance Clinical features for distinguishing between type 1 diabetes and other types of diabetes: What are the best clinical features or combination of features for distinguishing between type 1 diabetes and other types of diabetes? The use of C-peptide in diagnosing diabetes: What is the effectiveness of C‑peptide at correcting misclassification of diabetes diagnosis and what is the optimal timing for the test in distinguishing subtypes of diabetes? Use of routinely collected real-world data to examine the effectiveness and cost effectiveness of continuous glucose monitoring: Based on routinely collected real-world data, what is the effectiveness and cost effectiveness of CGM devices to improve glycaemic control?
Clinical features for distinguishing between type 1 diabetes and other types of diabetes: What are the best clinical features or combination of features for distinguishing between type 1 diabetes and other types of diabetes?
The use of C-peptide in diagnosing diabetes: What is the effectiveness of C‑peptide at correcting misclassification of diabetes diagnosis and what is the optimal timing for the test in distinguishing subtypes of diabetes?
Use of routinely collected real-world data to examine the effectiveness and cost effectiveness of continuous glucose monitoring: Based on routinely collected real-world data, what is the effectiveness and cost effectiveness of CGM devices to improve glycaemic control?